PYC Therapeutics Limited
Status: Publicly traded
Direct answer
PYC Therapeutics Limited is publicly traded on ASX under the ticker PYC.AX.
PYC Therapeutics Limited is an Australian-based pharmaceutical company dedicated to the research and development of ribonucleic acid (RNA)-based drug treatments. Its preclinical pipeline features VP-001, designed for retinitis pigmentosa type 11, and PYC-001, a therapeutic candidate for autosomal dominant optic atrophy. The firm is also actively developing solutions for various kidney, retinal, and central nervous...
Can you invest in PYC Therapeutics Limited?
Yes. PYC Therapeutics Limited trades publicly on ASX as PYC.AX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for PYC Therapeutics Limited
Detailed equity research is provided by MarketSnap.